Another promising drug target to develop anti‐malaria chemotherapy is the Plasmodium falciparum cysteine protease falcipain‐2, is one of four papain‐family cysteine proteases known as falcipains‐2 expressed by malaria parasite Plasmodium falciparum.17 The gene discussed is CTSB; the disease is malaria.